Largest Study Examines Long-Term Effects of COVID-19 on Kidney Health

A groundbreaking study analyzing over 13 million records reveals that severe COVID-19 infections significantly increase the risk of long-term kidney damage, while mild cases do not.
A comprehensive study involving over 13 million individuals in England has shed light on the long-term impact of COVID-19 on kidney health. The research indicates that mild COVID-19 infections, which do not require hospitalization, are unlikely to cause lasting kidney damage. However, patients who experience severe illness necessitating hospital care face a significantly elevated risk of developing kidney problems later on.
The study, conducted by researchers at the London School of Hygiene & Tropical Medicine (LSHTM) in collaboration with the University of Oxford's OpenSAFELY platform, analyzed electronic health records from February 2020 to December 2022. This platform enables secure, anonymized access to large-scale medical data, supporting detailed population health research without compromising patient privacy.
Data from more than 3.5 million individuals confirmed COVID-19 infection, while the remaining 10 million had no recorded infection. Patients already on dialysis or living with a kidney transplant were excluded to focus on new kidney function outcomes. The findings, published in The Lancet Regional Health—Europe, reveal that during the pandemic, severe COVID-19 cases requiring hospitalization were associated with a more than sevenfold increased risk of kidney failure, especially among those admitted to intensive care or experiencing acute kidney injury. In contrast, mild COVID-19 cases showed no increased risk for long-term kidney issues.
Research lead Dr. Viyaasan Mahalingasivam explained that this is the largest study to date investigating long-term kidney outcomes post-COVID-19. While acute kidney injury during severe infection was a common concern, the results are reassuring regarding milder cases. Nevertheless, the high risk linked to severe illness underscores the importance of preventive measures, including vaccination, particularly for vulnerable populations.
The study also observed disparities across different ethnic groups, with the highest risk of kidney damage among Black individuals. Senior author Prof. Laurie Tomlinson emphasized the need for ongoing monitoring of discharged COVID-19 patients and urged further research into health inequalities. The authors recommend focusing healthcare efforts on preventing severe disease through vaccination and early intervention to reduce long-term kidney risks associated with COVID-19.
Source: https://medicalxpress.com/news/2025-06-largest-date-term-impact-covid.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Harnessing Cerebellar Brain Signals to Control Prosthetic Devices
Cedars-Sinai researchers have discovered that brain signals from the cerebellum can be used to operate prosthetic devices, offering new hope for stroke rehabilitation and motor impairment solutions.
Antiviral Therapy Shows No Effect on Early-Stage Alzheimer's Progression
A groundbreaking clinical trial shows that antiviral medication does not slow the progression of early-stage Alzheimer's disease, challenging previous hypotheses linking herpes infections to the condition.
Kennedy's Vaccine Committee Endorses Preservative-Free Flu Shots for Fall
Kennedy's vaccine advisory panel recommends only preservative-free flu vaccines for all individuals aged 6 months and older, amid ongoing vaccine ingredient concerns and recent policy shifts.
Rapid Evolution of Bird Flu Enhances Infection and Spread Among Hosts
New research highlights the rapid evolution of the bird flu virus, showing increased infectivity, broader host range, and enhanced spread across regions, mainly driven by wild bird migration and genetic reassortment.